DKMA Update March 2018

28 March 2018

This newsletter features the following articles:

  • Evidence on the agenda
  • The SmPC for tramadol to be changed
  • Inspection of the sale of over-the-counter medicines outside pharmacies
  • Do not use Xofigo for treatment of prostate cancer in combination with Zytiga and the anti-inflammatory agents prednisone/prednisolone
  • Rare but possible risk of liver injury in the treatment of fibroids with the medicine Esmya
  • Multiple sclerosis medicine Zinbryta removed from the market

Short news:

  • New status report on biological medicines and biosimilars
  • Scientific advice to promote research and innovation
  • Short film about the medicinal cannabis pilot programme


DKMA Update March 2018 (pdf)

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.